aspirin has been researched along with Lacerations in 3 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Lacerations: Torn, ragged, mangled wounds.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We studied patients with stable coronary artery disease on chronic aspirin therapy randomised to addition of clopidogrel 75 mg/d (n = 30) or continuation of aspirin 100 mg/d (n = 30) for 4 weeks." | 9.14 | Thrombin formation and platelet activation at the site of vascular injury in patients with coronary artery disease treated with clopidogrel combined with aspirin. ( Branicka, A; Stepień, E; Tracz, W; Undas, A; Wołkow, P; Zmudka, K, 2009) |
| "We studied patients with stable coronary artery disease on chronic aspirin therapy randomised to addition of clopidogrel 75 mg/d (n = 30) or continuation of aspirin 100 mg/d (n = 30) for 4 weeks." | 5.14 | Thrombin formation and platelet activation at the site of vascular injury in patients with coronary artery disease treated with clopidogrel combined with aspirin. ( Branicka, A; Stepień, E; Tracz, W; Undas, A; Wołkow, P; Zmudka, K, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Noland, SS | 1 |
| Paul, AW | 1 |
| Pflibsen, LR | 1 |
| Rizzo, M | 1 |
| Undas, A | 1 |
| Stepień, E | 1 |
| Branicka, A | 1 |
| Wołkow, P | 1 |
| Zmudka, K | 1 |
| Tracz, W | 1 |
| Kosar, A | 1 |
| Cipil, HS | 1 |
| Kaya, A | 1 |
| Uz, B | 1 |
| Haznedaroglu, IC | 1 |
| Goker, H | 1 |
| Ozdemir, O | 1 |
| Ercetin, S | 1 |
| Kirazli, S | 1 |
| Firat, HC | 1 |
1 trial available for aspirin and Lacerations
| Article | Year |
|---|---|
Thrombin formation and platelet activation at the site of vascular injury in patients with coronary artery disease treated with clopidogrel combined with aspirin.
Topics: Aspirin; Biomarkers; CD40 Ligand; Clopidogrel; Coronary Artery Disease; Drug Administration Schedule | 2009 |
2 other studies available for aspirin and Lacerations
| Article | Year |
|---|---|
The Effect of Anticoagulation on the Treatment of Dupuytren Contracture with Collagenase.
Topics: Anticoagulants; Aspirin; Clostridium histolyticum; Dupuytren Contracture; Hematoma; Humans; Injectio | 2022 |
The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model.
Topics: Analysis of Variance; Animals; Anticoagulants; Aspirin; Disease Models, Animal; Enoxaparin; Female; | 2009 |